Literature DB >> 12806213

Cytokines in the pathogenesis of cancer cachexia.

Josep M Argilés1, Sílvia Busquets, Francisco J López-Soriano.   

Abstract

PURPOSE OF REVIEW: The aim of the present review is to summarize and update the role of different cytokines in the pathogenesis of cancer cachexia and to provide therapeutic strategies based on cytokine action. RECENT
FINDINGS: Cancer cachexia is a syndrome characterized by a marked weight loss, anorexia, asthenia and anemia. The cachectic state is invariably associated with the presence and growth of the tumor and leads to a malnutrition status due to the induction of anorexia or decreased food intake. In addition, the competition for nutrients between the tumor and the host leads to an accelerated starvation state which promotes severe metabolic disturbances in the host, including hypermetabolism, which leads to an increased energetic inefficiency. Different cytokines are clearly implicated in this process, possibly being responsible for anorexia, hypermetabolism and many other metabolic abnormalities, such as muscle proteolysis and apoptosis.
SUMMARY: Although the search for the cachectic factor(s) started a long time ago, and although many scientific and economic efforts have been devoted to its discovery, we are still a long way from knowing the whole truth. A lot of progress has been made, however, in understanding the role of different cytokines - tumor necrosis factor and IL-6 in particular - in muscle wasting associated with cancer cachexia, perhaps the most paradigmatic feature of this complex syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12806213     DOI: 10.1097/01.mco.0000078983.18774.cc

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  48 in total

1.  JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.

Authors:  Andrea Bonetto; Tufan Aydogdu; Xiaoling Jin; Zongxiu Zhang; Rui Zhan; Leopold Puzis; Leonidas G Koniaris; Teresa A Zimmers
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-05       Impact factor: 4.310

Review 2.  Cellular and molecular events controlling skeletal muscle mass in response to altered use.

Authors:  François B Favier; Henri Benoit; Damien Freyssenet
Journal:  Pflugers Arch       Date:  2008-01-12       Impact factor: 3.657

3.  Low nutritional prognostic index correlates with poor survival in patients with stage IV colorectal cancer following palliative resection of the primary tumor.

Authors:  Kiyoshi Maeda; Masatsune Shibutani; Hiroshi Otani; Hisashi Nagahara; Kenji Sugano; Teturo Ikeya; Naoshi Kubo; Ryosuke Amano; Kenjiro Kimura; Kazuya Muguruma; Hiroaki Tanaka; Kosei Hirakawa
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

Review 4.  Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

Authors:  Umberto Cillo; Tommaso Giuliani; Marina Polacco; Luz Maria Herrero Manley; Gino Crivellari; Alessandro Vitale
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 5.  Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review.

Authors:  Benjamin H L Tan; James A Ross; Stein Kaasa; Frank Skorpen; Kenneth C H Fearon
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

6.  The role of IL-1β and TNF-α signaling in the genesis of cancer treatment related symptoms (CTRS): a study using cytokine receptor-deficient mice.

Authors:  Logan B Smith; Michael C Leo; Caroline Anderson; Teresa J Wright; Kristianna B Weymann; Lisa J Wood
Journal:  Brain Behav Immun       Date:  2014-01-08       Impact factor: 7.217

7.  Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study.

Authors:  G Engström; B Hedblad; L Janzon; F Lindgärde
Journal:  Diabetologia       Date:  2005-11-11       Impact factor: 10.122

8.  A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).

Authors:  Aminah Jatoi; Howard L Ritter; Amylou Dueck; Phuong L Nguyen; Daniel A Nikcevich; Ronnie F Luyun; Bassam I Mattar; Charles L Loprinzi
Journal:  Lung Cancer       Date:  2009-08-08       Impact factor: 5.705

Review 9.  Biomarkers for cancer cachexia: is there also a genetic component to cachexia?

Authors:  B H L Tan; D A C Deans; R J E Skipworth; J A Ross; K C H Fearon
Journal:  Support Care Cancer       Date:  2007-12-11       Impact factor: 3.603

10.  The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease.

Authors:  Sheryl F Vondracek; Norbert F Voelkel; Michael T McDermott; Connie Valdez
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.